| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/30/2011 | EP2300009A1 Oral administration of peripherally-acting opioid antagonists |
| 03/30/2011 | EP2300004A2 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 03/30/2011 | EP2299981A1 Sublingual compositions comprising (2s) - (4e) -n-methyl-5- (3- (5-isopropoxypyridin) yl) -4-penten-2-amine |
| 03/30/2011 | EP2299824A1 Pyrazole derivatives useful as inhibitors of faah |
| 03/30/2011 | EP2299822A2 Method for treating neurodegenerative dysfunction |
| 03/30/2011 | EP2299814A1 Compositions, synthesis, and methods of using piperazine based antipsychotic agents |
| 03/30/2011 | EP2217597B1 Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives as alpha 7 nicotinic acetylcholine receptor ligands for the treatment of alzheimer's disease |
| 03/30/2011 | EP2150253B1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas |
| 03/30/2011 | EP2125736B1 Substituted acetophenones useful as pde4 inhibitors |
| 03/30/2011 | EP1937687B1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE |
| 03/30/2011 | EP1898908B1 Novel chemical compounds and the uses thereof as a medicament |
| 03/30/2011 | EP1804919B1 Cgrp receptor antagonists |
| 03/30/2011 | EP1507515B1 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 03/30/2011 | EP1503773B1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 03/30/2011 | EP1458888B1 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene |
| 03/30/2011 | EP1409006B1 Monodispersed mixtures and methods of treating diabetes |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | CN1976710B Compounds and compositions as cathepsin S inhibitors |
| 03/30/2011 | CN1966500B Quinoxaline derivative, preparation method and uses |
| 03/30/2011 | CN1950101B Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| 03/30/2011 | CN1946398B Thiadiazolidinones as gsk-3 inhibitors |
| 03/30/2011 | CN1913907B Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue |
| 03/30/2011 | CN1814040B Compound liquid capsule of Chinese caterpillar fungus and quality control method |
| 03/30/2011 | CN1780855B Human il-1 beta antagonists |
| 03/30/2011 | CN101998956A Fluorinated dihydrotetrabenazine ether imaging agents and probes |
| 03/30/2011 | CN101998866A Oligomer-aryloxy-substituted propanamine conjugates |
| 03/30/2011 | CN101998863A Use of anti-amyloid beta antibody in ocular diseases |
| 03/30/2011 | CN101998854A Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/30/2011 | CN101993281A Culture medium of ganoderma capense (Lloyd) Teng fungus for preparing Baozhi glycopeptide injection |
| 03/30/2011 | CN101991861A Preparation method of gamma-Fe2O3/polyaniline-L-dopa |
| 03/30/2011 | CN101991859A Beta-cyclodextrin inclusion compound of huperzine A, and preparation method and preparation thereof |
| 03/30/2011 | CN101991817A Brain strengthening and nerve calming medicament |
| 03/30/2011 | CN101991814A 一种具有祛风化痰和活血通络功能的制剂及制备方法 Formulation and preparation method of expelling phlegm and have Huoxuetongluo function |
| 03/30/2011 | CN101991798A Medicament for treating apoplexy |
| 03/30/2011 | CN101991785A Lonicerae and Forsythiae detoxication soft capsule medicine and preparation method and quality detection method thereof |
| 03/30/2011 | CN101991774A Medicine for treating insomnia and preparation method thereof |
| 03/30/2011 | CN101991769A Traditional Chinese medicine composition for treating heart-kidney imbalance |
| 03/30/2011 | CN101991766A Medicament for facilitating sleep and preparation method and application thereof |
| 03/30/2011 | CN101991765A Paste capable of tranquilizing mind and helping sleep |
| 03/30/2011 | CN101991748A Method for preparing bighead atractylodes rhizome and liquorice pills |
| 03/30/2011 | CN101991739A Traditional Chinese medicine preparation for treating facial neural paralysis |
| 03/30/2011 | CN101991735A External-application ointment |
| 03/30/2011 | CN101991729A Medicinal liquor for relaxing muscles and tendons |
| 03/30/2011 | CN101991727A Medical composition for treating central nervous coordination disorders and preparation method thereof |
| 03/30/2011 | CN101991697A Preparation with functions of clearing away heat and reducing fire and preparation method thereof |
| 03/30/2011 | CN101991679A Orally-taking Chinese medicine for treating anhypnia |
| 03/30/2011 | CN101991666A Ointment for treating pain in neck, shoulder, waist and legs and preparation method thereof |
| 03/30/2011 | CN101991638A Medicine composition for treating facial paralysis as well as preparation method and application thereof |
| 03/30/2011 | CN101991628A Process for preparing non-toxic extractive from asarum heterotropoides |
| 03/30/2011 | CN101991625A Large tranquilizing pill and preparation method thereof |
| 03/30/2011 | CN101991622A Preparation process of Nitraria schoberi L seed oil liposome |
| 03/30/2011 | CN101991620A Medicament prepared from okra extractive and application thereof |
| 03/30/2011 | CN101991615A Method for producing ganoderma spore by breaking wall |
| 03/30/2011 | CN101991612A Preparation method of haematococcus pluvialis extracts |
| 03/30/2011 | CN101991604A Forest frog oil capsules and preparation method |
| 03/30/2011 | CN101991603A Preparation for treating cold in children and preparation method |
| 03/30/2011 | CN101991602A New method for preparing compound cerebroprotin hydrolysate |
| 03/30/2011 | CN101991592A Application of paederoside to preparation of analgesic and/or anti-inflammatory medicaments |
| 03/30/2011 | CN101991577A Novel mental medicinal composition |
| 03/30/2011 | CN101991576A Use of xanthine compound and pharmaceutical composition thereof |
| 03/30/2011 | CN101991568A Application of senkyunolide I in preparation of antidepressant medicament, migraine medicament and medicaments for other diseases relevant to 5-hydroxytryptamine system |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101991564A Production process for separating, extracting and purifying bioactive substance calcium nervonate and application thereof to treatment of Alzheimer's disease |
| 03/30/2011 | CN101991561A 3,4-dichlorophenyl-propenoyl-sec-butylamine composition |
| 03/30/2011 | CN101991559A Stable Agomelatine capsule medicine composition |
| 03/30/2011 | CN101991555A Quetiapine fumarate tablet and preparation method thereof |
| 03/30/2011 | CN101991548A Reduced glutathione freeze-dried powder injection and preparation method thereof |
| 03/30/2011 | CN101991545A Caffeine slow-release micro pill preparation and preparation method thereof |
| 03/30/2011 | CN101991535A Docosahexaenoic acid (DHA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 03/30/2011 | CN101991534A EPA (eicoeapentaenoieaeid) ester fat emulsion intravenous injection and preparation method thereof |
| 03/30/2011 | CN101991530A Vinpocetine containing high-capacity sodium chloride injection and preparation method thereof |
| 03/30/2011 | CN101991520A Washing-free bath cream with sleeping function and preparation method thereof |
| 03/30/2011 | CN101991319A Novel Chinese medicament-plant health care pillow |
| 03/30/2011 | CN101991099A Ginseng can |
| 03/30/2011 | CN101712649B Lotus leaf extract, monomer component and application thereof |
| 03/30/2011 | CN101417084B Traditional Chinese medicine for treating sciatica and preparation method thereof |
| 03/30/2011 | CN101322748B Hypericum perforatum total flavones and formulation preparation and quality testing method |
| 03/30/2011 | CN101185643B Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 03/30/2011 | CN101167697B Donepezils compound long-acting slow-releasing and controlled-releasing composition and preparation method thereof |
| 03/30/2011 | CN101133027B Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 03/30/2011 | CN101073351B Memory-enhancing tea with brain-invigorating and vision-improving functions |
| 03/30/2011 | CN101029302B Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 03/29/2011 | US7915420 Aryl piperidine amides |
| 03/29/2011 | US7915419 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/29/2011 | US7915413 Compounds |
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7915307 Methods of improving the pharmacokinetics of doxepin |
| 03/29/2011 | US7915286 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| 03/29/2011 | US7915284 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 03/29/2011 | US7915265 Combinations for the treatment of immunoinflammatory disorders |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7915258 Substituted 2,5-dihydro-3H-pyrazolo[4,3-C]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same |
| 03/29/2011 | US7915246 Milnacipran; sub-class of dual serotonin norepinephrine reuptake inhibitors characterized by a non-tricyclic structure and inhibit the reuptake of norepinephrine to an equal or greater extent than they inhibit the reuptake of serotonin; with gabapentin, pregabalin; no phenylalanine, tyrosine, tryptophan |
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | US7915226 Methods of suppressing microglial activation |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | US7914818 Prevent drug abruse; side effect reduction; administering mixture of opioid antagonist, releasable form and sequestering agent |